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APPELLANT'S REPLY TO RESPONDENT'S BRIEF 
Appellant hereby replies, pursuant to Rule 24(c) of the Rules 
of the Utah Supreme Court, to new matters set forth in the Brief 
of Respondent: 
NEW MATTERS SET FORTH IN RESPONDENT'S BRIEF 
1. Searle asserts that the affidavit of King's expert 
witness, Robert E. Baier, Ph.D., is insufficient to establish a 
prima facie case against Searle, because it was filed after the 
date set by the District Court for designation of King's expert 
witnesses. (Respondent's Brief, p.10) 
2. Searle argues that King cannot rely upon res ipsa 
loquitur because the issue is raised for the first time on appeal. 
(Respondent's Brief, p. 14) 
3. Searle asserts that because King's other expert witness, 
Charles W. March, M.D., is not critical of the Cu-7, then the 
affidavit of Dr. Baier is insufficient to create a prima facie 
case. (Respondent's Brief, p. 15) 
ARGUMENT 
I. THE ISSUE AS TO WHETHER THE AFFIDAVIT OF APPELLANT'S EXPERT, 
DR. ROBERT E. BAIER WAS UNTIMELY FILED IS MOOT. 
King concedes the fact that the affidavit of Dr. Robert E. 
Baier was filed after the date designated in the Scheduling Order 
(R. 177) for the naming of King's expert witnesses. However, in 
Affidavits (R. 266) and in oral arguments before the District Court 
(R. 511-514) King demonstrated that the failure to designate expert 
witnesses as per the scheduling order was due to the fact that she 
had been abandoned by her original expert, so that she was forced 
at the last minute to seek alternate expert assistance. King 
explained that this event was unexpected and unavoidable, and that 
she had immediately taken action to retain other experts so as to 
be able to comply with the District Court's Scheduling Order. (R. 
2 66, R. 408) King further informed the District Court that she 
had indeed retained other experts, but asked that she be granted 
additional time in which to obtain affidavits from the experts 
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(R. 264) before responding to Searle's Motion for Summary 
Judgement. The District Court denied King's motion on the grounds 
that she had not yet named the experts as required by the 
Scheduling Order, and that she had not demonstrated that the 
experts1 testimony would create a material issue of fact as to 
Searle Pharmaceuticals. (R. 310) 
King then filed a Motion for Relief pursuant to URCP 60(b), 
arguing that her failure to designate an expert was due to mistake 
and excusable neglect, and that, while certainly sanctions might 
be imposed for failure to comply with the Scheduling Order, Summary 
Judgment was inappropriate. Oral Arguments upon the Motion for 
Relief were scheduled, and the District Court indicated that it 
would not enter the Order of Summary Judgment until after the 
hearing which occurred on 15 January, 1988. 
The District Court in its Ruling of 27 January, 1988, 
specifically stated that King had responded to Searlefs Motion for 
Summary Judgment, and that this response had been fully considered 
by the Court. (R. 457) The Court further stated that it was 
refusing Searlefs proposed Order which denied Plaintiff's Motion 
for Extension of Time in which to Answer Searlefs Motion for 
Summary Judgment, and was returning that document, unsigned to 
Searle. (R. 461) In so ruling, the District Court Clearly opted 
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to accept the Affidavit of Dr. Baier. The issue of timeliness 
became moot. 
The Ruling which explains the rationale for the District 
Courtfs decision to enter Summary Judgment deals entirely with, 
what the District Court perceived to be, defects in Dr. Baierfs 
affidavit. The Court's ruling as to summary judgment was based on 
the issue of whether Dr. Baier!s affidavit was sufficient to create 
a material question of fact as to the element of causation. It is 
that issue, alone, which is the subject of the present appeal. 
II. THE DOCTRINE OF RES IPSA LOQUITUR HAS BEEN RELIED UPON BY 
APPELLANT SINCE THE INCEPTION OF THIS LAWSUIT. 
Searle is mistaken when it asserts that King relies upon res 
ipsa loquitur for the first time upon appeal. King first 
specifically alleged that the doctrine should be applied as to her 
claim against Searle Pharmaceuticals in her Complaint at paragraphs 
36 through 39, under the section entitled "Second Cause of Action -
Defendant Searle Pharmaceuticals" (R. 7-8) . In addition, the 
applicability of the doctrine was extensively argued before the 
District Court in oral arguments on 15 January, 1988. Res ipsa has 
been an important theory of King's case since its commencement. 
Clearly the issue was not raised for the first time on appeal. 
King has adequately demonstrated each of the elements which 
are prerequisites to the application of the doctrine. She was 
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relieved of the necessity of demonstrating a causal connection 
between the instrumentality controlled by the defendants and her 
injury, because that causal connection is conceded by the parties: 
the fact that the Cu-7 perforated King's uterus is admitted by all 
concerned. King thus established a prima facie case against 
Searle, separate and apart from her claim of Strict Liability in 
Tort to which the Affidavit of Dr. Robert E. Baier pertains, 
III. IT IS IRRELEVANT THAT APPELLANT'S OTHER EXPERT, CHARLES M. 
MARCH, M.D., DOES NOT CRITICIZE THE CU-7. 
Respondent's Brief quotes portions of the deposition of King's 
other expert witness, Charles March, M.D. (Respondent's Brief, p. 
15) , who testified that he had seen no conclusive evidence to 
indicate that the Cu-7 was an unsafe device. It is entirely 
possible that Searle may elicit similar testimony from Dr- March 
at trial. This does not negate that fact, however, that the 
affidavit of Dr. Robert Baier creates genuine questions of fact 
concerning the safety of the Cu-7, and the causal connection 
between the action of the device and the injuries sustained by 
King. 
Dr. March was retained by King to testify as to the 
allegations of medical malpractice against defendant Doran V. 
Porter, M.D. Dr. March was not asked to critique Dr. Baier's 
research or conclusions, nor was he acquainted with Dr. Baierfs 
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work, the results of which have not yet been published. His 
comments cannot be construed as direct refutation of Dr. Baier's 
opinions. Should Dr. March acquaint himself with Dr. Baier's work 
and remain steadfast in his opinion as to the safety of the Cu-7, 
it will become the function of the jury to weigh that testimony 
with the other evidence before them. 
CONCLUSION 
The affidavit of Dr. Robert Baier established compelling 
evidence of a causal connection between the destructive action of 
the Cu-7 upon living tissues and the perforation of Debra King's 
uterus. There is clearly sufficient evidence to create a jury 
question as to the proximate cause of King's injuries. 
Appellant respectfully submits that the Summary Judgment 
entered in favor of Searle Pharmaceuticals should be reversed. 
DATED this ^ / day of j^^2^^> ~ , 1988. 
/^^r^^ ^^ 
WAYNtf/6. WATSON, P.C. 
Attorney for Appellant 
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